
Ravi Singhal
About Ravi Singhal
Data last updated:
Ravi Singhal is a Ceo at Biotech International Limited (since 2016), Director at Chemicals International Private Limited (since 2013) and Director at Computronics International Limited (since 2013). The companies operate in Agriculture, Consumer Electronics & Durables and Financial Services. The 3 current companies with reported revenue have a combined latest revenue of ₹20.48 Cr; the largest is Biotech International Limited at ₹17.78 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Ceo | 01 May 2016 | 1993 | ₹17.78 Cr (FY 2025) | Active | |
| Director | 30 Aug 2013 | 1971 | ₹1.70 Cr (FY 2025) | Active | |
| Director | 30 Aug 2013 | 1993 | ₹1.00 Cr (FY 2025) | Active |
Board colleagues of Ravi Singhal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Manjula Singhal | 01046331 | Biotech International Limited , Chemicals International Private Limited and 1 more | Director |
| Mr. Ravi Singhal | Biotech International Limited | Ceo | |
| Saurabh Singhal | 01046335 | Biotech International Limited , Chemicals International Private Limited and 1 more | Managing Director |
| Shahji Dhar | 08121829 | Biotech International Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ravi Singhal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ravi Singhal
Ravi Singhal currently holds 3 directorships: Biotech International Limited (Ceo, since 01 May 2016, revenue ₹17.78 Cr (FY 2025)); Chemicals International Private Limited (Director, since 30 Aug 2013, revenue ₹1.70 Cr (FY 2025)); Computronics International Limited (Director, since 30 Aug 2013, revenue ₹1.00 Cr (FY 2025)).
Ravi Singhal was first appointed on 30 Aug 2013 as Director at Chemicals International Private Limited. The most recent appointment on record is 01 May 2016 at Biotech International Limited.
The 3 current companies of Ravi Singhal that report revenue have a combined latest revenue of ₹20.48 Cr: Biotech International Limited ₹17.78 Cr (FY 2025); Chemicals International Private Limited ₹1.70 Cr (FY 2025); Computronics International Limited ₹1.00 Cr (FY 2025).
The current boards of Ravi Singhal's companies include Manjula Singhal (Biotech International Limited), Mr. Ravi Singhal (Biotech International Limited), Saurabh Singhal (Biotech International Limited), Shahji Dhar (Biotech International Limited).